Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Microbial risk factors for treatment failure of pivmecillinam in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.

Syre H, Hetland MAK, Bernhoff E, Bollestad M, Grude N, Simonsen GS, Löhr IH.

APMIS. 2019 Nov 22. doi: 10.1111/apm.13013. [Epub ahead of print]

PMID:
31755584
2.

Antimicrobial resistance is a super wicked problem.

Littmann J, Simonsen GS.

Tidsskr Nor Laegeforen. 2019 Oct 31;139(16). doi: 10.4045/tidsskr.19.0478. Print 2019 Nov 5. Norwegian, English. No abstract available.

3.

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance.

Vandenbroucke-Grauls CMJE, Kahlmeter G, Kluytmans J, Kluytmans-van den Bergh M, Monnet DL, Simonsen GS, Skov RL, Wolff Sönksen U, Voss A.

BMJ Glob Health. 2019 Aug 21;4(4):e001838. doi: 10.1136/bmjgh-2019-001838. eCollection 2019. No abstract available.

4.

Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.

Jarlier V, Diaz Högberg L, Heuer OE, Campos J, Eckmanns T, Giske CG, Grundmann H, Johnson AP, Kahlmeter G, Monen J, Pantosti A, Rossolini GM, van de Sande-Bruinsma N, Vatopoulos A, Żabicka D, Žemličková H, Monnet DL, Simonsen GS; Ears-Net Participants.

Euro Surveill. 2019 Aug;24(33). doi: 10.2807/1560-7917.ES.2019.24.33.1800538.

5.

Culturing periprosthetic tissue in BacT/Alert® Virtuo blood culture system leads to improved and faster detection of prosthetic joint infections.

Sanabria A, Røkeberg MEO, Johannessen M, Sollid JE, Simonsen GS, Hanssen AM.

BMC Infect Dis. 2019 Jul 10;19(1):607. doi: 10.1186/s12879-019-4206-x.

6.

Hormonal contraceptive use and Staphylococcus aureus nasal and throat carriage in a Norwegian youth population.

Stensen DB, Småbrekke L, Olsen K, Grimnes G, Nielsen CS, Simonsen GS, Sollid JUE, Furberg AS.

PLoS One. 2019 Jul 5;14(7):e0218511. doi: 10.1371/journal.pone.0218511. eCollection 2019.

7.

The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation package.

Hays JP, Mitsakakis K, Luz S, van Belkum A, Becker K, van den Bruel A, Harbarth S, Rex JH, Simonsen GS, Werner G, Di Gregori V, Lüdke G, van Staa T, Moran-Gilad J, Bachmann TT; JPIAMR AMR-RDT consortium.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1015-1022. doi: 10.1007/s10096-019-03492-4. Epub 2019 Feb 2. Review.

8.

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL; Burden of AMR Collaborative Group.

Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.

9.

Antimicrobial resistance surveillance in Europe and beyond.

Simonsen GS.

Euro Surveill. 2018 Oct;23(42). doi: 10.2807/1560-7917.ES.2018.23.42.1800560. No abstract available.

10.

Participatory implementation of an antibiotic stewardship programme supported by an innovative surveillance and clinical decision-support system.

Simões AS, Maia MR, Gregório J, Couto I, Asfeldt AM, Simonsen GS, Póvoa P, Viveiros M, Lapão LV.

J Hosp Infect. 2018 Nov;100(3):257-264. doi: 10.1016/j.jhin.2018.07.034. Epub 2018 Jul 30.

PMID:
30071264
11.

Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study.

Bollestad M, Grude N, Solhaug S, Raffelsberger N, Handal N, Nilsen HS, Romstad MR, Emmert A, Tveten Y, Søraas A, Jenum PA, Jenum S, Møller-Stray J, Weme ET, Lindbaek M, Simonsen GS; (the Norwegian ESBL UTI study group).

J Antimicrob Chemother. 2018 Sep 1;73(9):2503-2509. doi: 10.1093/jac/dky230.

PMID:
29982514
12.

Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.

Chirindze LM, Zimba TF, Sekyere JO, Govinden U, Chenia HY, Sundsfjord A, Essack SY, Simonsen GS.

BMC Infect Dis. 2018 May 30;18(1):244. doi: 10.1186/s12879-018-3154-1.

13.

Stratification by interferon-γ release assay level predicts risk of incident TB.

Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM.

Thorax. 2018 Apr 5. pii: thoraxjnl-2017-211147. doi: 10.1136/thoraxjnl-2017-211147. [Epub ahead of print]

PMID:
29622693
14.

Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control.

Magiorakos AP, Burns K, Rodríguez Baño J, Borg M, Daikos G, Dumpis U, Lucet JC, Moro ML, Tacconelli E, Simonsen GS, Szilágyi E, Voss A, Weber JT.

Antimicrob Resist Infect Control. 2017 Nov 15;6:113. doi: 10.1186/s13756-017-0259-z. eCollection 2017.

15.

[Antibiotic resistance must be fought globally].

Simonsen GS, Eriksen HM, Steinbakk M.

Tidsskr Nor Laegeforen. 2017 Nov 13;137(21). doi: 10.4045/tidsskr.17.0866. Print 2017 Nov 14. Norwegian. No abstract available.

16.

Antibiotics to outpatients in Norway-Assessing effect of latitude and municipality population size using quantile regression in a cross-sectional study.

Haugen P, Simonsen GS, Primicerio R, Furberg AS, Småbrekke L.

Pharm Stat. 2018 Feb;17(1):4-11. doi: 10.1002/pst.1831. Epub 2017 Sep 29.

PMID:
28961357
17.

Systemic antibiotic prophylaxis prior to gastrointestinal surgery - is oral administration of doxycycline and metronidazole adequate?

Giske A, Nymo LS, Fuskevåg OM, Amundsen S, Simonsen GS, Lassen K.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):785-791. doi: 10.1080/23744235.2017.1342044. Epub 2017 Jun 28.

PMID:
28657405
18.

Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity.

Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections.

J Clin Microbiol. 2017 Jul;55(7):2234-2248. doi: 10.1128/JCM.00150-17. Epub 2017 May 10.

19.

Use of antibiotics in hospitals and nursing homes.

Simonsen GS.

Tidsskr Nor Laegeforen. 2017 Mar 7;137(5):340. doi: 10.4045/tidsskr.16.0849. eCollection 2017 Mar. English, Norwegian. No abstract available.

20.

Norwegian patients and retail chicken meat share cephalosporin-resistant Escherichia coli and IncK/blaCMY-2 resistance plasmids.

Berg ES, Wester AL, Ahrenfeldt J, Mo SS, Slettemeås JS, Steinbakk M, Samuelsen Ø, Grude N, Simonsen GS, Løhr IH, Jørgensen SB, Tofteland S, Lund O, Dahle UR, Sunde M.

Clin Microbiol Infect. 2017 Jun;23(6):407.e9-407.e15. doi: 10.1016/j.cmi.2016.12.035. Epub 2017 Jan 7.

21.

Antibiotic Use in Children - A Cross-National Analysis of 6 Countries.

Youngster I, Avorn J, Belleudi V, Cantarutti A, Díez-Domingo J, Kirchmayer U, Park BJ, Peiró S, Sanfélix-Gimeno G, Schröder H, Schüssel K, Shin JY, Shin SM, Simonsen GS, Blix HS, Tong A, Trifirò G, Ziv-Baran T, Kim SC.

J Pediatr. 2017 Mar;182:239-244.e1. doi: 10.1016/j.jpeds.2016.11.027. Epub 2016 Dec 21.

PMID:
28012694
22.

Bifidobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics.

Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C.

Emerg Infect Dis. 2016 Sep;22(9):1664-6. doi: 10.3201/eid2209.160033. No abstract available.

23.

Early-onset Sepsis and Antibiotic Exposure in Term Infants: A Nationwide Population-based Study in Norway.

Fjalstad JW, Stensvold HJ, Bergseng H, Simonsen GS, Salvesen B, Rønnestad AE, Klingenberg C.

Pediatr Infect Dis J. 2016 Jan;35(1):1-6. doi: 10.1097/INF.0000000000000906.

PMID:
26368059
24.

Integron, Plasmid and Host Strain Characteristics of Escherichia coli from Humans and Food Included in the Norwegian Antimicrobial Resistance Monitoring Programs.

Sunde M, Simonsen GS, Slettemeås JS, Böckerman I, Norström M.

PLoS One. 2015 Jun 5;10(6):e0128797. doi: 10.1371/journal.pone.0128797. eCollection 2015.

25.

European survey on principles of prudent antibiotic prescribing teaching in undergraduate students.

Pulcini C, Wencker F, Frimodt-Møller N, Kern WV, Nathwani D, Rodríguez-Baño J, Simonsen GS, Vlahović-Palčevski V, Gyssens IC; ESGAP Curriculum Working Group.

Clin Microbiol Infect. 2015 Apr;21(4):354-61. doi: 10.1016/j.cmi.2014.11.015. Epub 2014 Nov 22.

26.

Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.

Hegstad K, Longva JÅ, Hide R, Aasnæs B, Lunde TM, Simonsen GS.

Scand J Infect Dis. 2014 Oct;46(10):712-5. doi: 10.3109/00365548.2014.923107. Epub 2014 Aug 19.

PMID:
25134650
27.

Power law approximations of movement network data for modeling infectious disease spread.

Geilhufe M, Held L, Skrøvseth SO, Simonsen GS, Godtliebsen F.

Biom J. 2014 May;56(3):363-82.

PMID:
24843881
28.

Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6')-Ib.

Haldorsen BC, Simonsen GS, Sundsfjord A, Samuelsen O; Norwegian Study Group on Aminoglycoside Resistance.

Diagn Microbiol Infect Dis. 2014 Jan;78(1):66-9. doi: 10.1016/j.diagmicrobio.2013.10.001. Epub 2013 Oct 14.

PMID:
24231381
29.

Factors associated with Chlamydia trachomatis testing in a high school based screening and previously in clinical practice: a cross-sectional study in Norway.

Gravningen K, Simonsen GS, Furberg AS, Wilsgaard T.

BMC Infect Dis. 2013 Aug 1;13:361. doi: 10.1186/1471-2334-13-361.

30.

Large IncHI2-plasmids encode extended-spectrum β-lactamases (ESBLs) in Enterobacter spp. bloodstream isolates, and support ESBL-transfer to Escherichia coli.

Nilsen E, Haldorsen BC, Sundsfjord A, Simonsen GS, Ingebretsen A, Naseer U, Samuelsen O; Norwegian Study Group on Invasive Enterobacter.

Clin Microbiol Infect. 2013 Nov;19(11):E516-8. doi: 10.1111/1469-0691.12274. Epub 2013 Jun 25.

31.

Obesity and Staphylococcus aureus nasal colonization among women and men in a general population.

Olsen K, Danielsen K, Wilsgaard T, Sangvik M, Sollid JU, Thune I, Eggen AE, Simonsen GS, Furberg AS.

PLoS One. 2013 May 7;8(5):e63716. doi: 10.1371/journal.pone.0063716. Print 2013.

32.

Early sexual behaviour and Chlamydia trachomatis infection - a population based cross-sectional study on gender differences among adolescents in Norway.

Gravningen K, Furberg AS, Simonsen GS, Wilsgaard T.

BMC Infect Dis. 2012 Nov 22;12:319. doi: 10.1186/1471-2334-12-319.

33.

Increased high-level gentamicin resistance in invasive Enterococcus faecium is associated with aac(6')Ie-aph(2″)Ia-encoding transferable megaplasmids hosted by major hospital-adapted lineages.

Rosvoll TC, Lindstad BL, Lunde TM, Hegstad K, Aasnaes B, Hammerum AM, Lester CH, Simonsen GS, Sundsfjord A, Pedersen T.

FEMS Immunol Med Microbiol. 2012 Nov;66(2):166-76. doi: 10.1111/j.1574-695X.2012.00997.x. Epub 2012 Jun 27.

34.

Multilocus sequence typing of genital Chlamydia trachomatis in Norway reveals multiple new sequence types and a large genetic diversity.

Gravningen K, Christerson L, Furberg AS, Simonsen GS, Ödman K, Ståhlsten A, Herrmann B.

PLoS One. 2012;7(3):e34452. doi: 10.1371/journal.pone.0034452. Epub 2012 Mar 28.

35.

Prevalence and population structure of Staphylococcus aureus nasal carriage in healthcare workers in a general population. The Tromsø Staph and Skin Study.

Olsen K, Sangvik M, Simonsen GS, Sollid JU, Sundsfjord A, Thune I, Furberg AS.

Epidemiol Infect. 2013 Jan;141(1):143-52. doi: 10.1017/S0950268812000465. Epub 2012 Mar 22.

36.

Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe.

Kuch A, Willems RJ, Werner G, Coque TM, Hammerum AM, Sundsfjord A, Klare I, Ruiz-Garbajosa P, Simonsen GS, van Luit-Asbroek M, Hryniewicz W, Sadowy E.

J Antimicrob Chemother. 2012 Mar;67(3):551-8. doi: 10.1093/jac/dkr544. Epub 2011 Dec 29.

PMID:
22207599
37.

Age- and gender-associated Staphylococcus aureus spa types found among nasal carriers in a general population: the Tromso Staph and Skin Study.

Sangvik M, Olsen RS, Olsen K, Simonsen GS, Furberg AS, Sollid JU.

J Clin Microbiol. 2011 Dec;49(12):4213-8. doi: 10.1128/JCM.05290-11. Epub 2011 Oct 12.

38.

Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study.

Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, Grimnes G, Jorde R, Simonsen GS, Furberg AS.

Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):465-73. doi: 10.1007/s10096-011-1331-x. Epub 2011 Aug 3.

39.

Comparative activity of tigecycline and tetracycline on Gram-negative and Gram-positive bacteria revealed by a multicentre study in four North European countries.

Nilsson LE, Frimodt-Møller N, Vaara M, Simonsen GS; Tigecycline Study Group.

Scand J Infect Dis. 2011 Sep;43(9):707-13. doi: 10.3109/00365548.2011.581305. Epub 2011 May 30.

PMID:
21619494
40.

Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway.

Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø; Norwegian Study Group of Acinetobacter.

J Antimicrob Chemother. 2011 Apr;66(4):738-44. doi: 10.1093/jac/dkq521. Epub 2011 Jan 19.

PMID:
21393175
41.

Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures.

Johnsen PJ, Townsend JP, Bøhn T, Simonsen GS, Sundsfjord A, Nielsen KM.

J Antimicrob Chemother. 2011 Mar;66(3):608-10. doi: 10.1093/jac/dkq512. Epub 2011 Jan 7.

42.

Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages.

Sletvold H, Johnsen PJ, Wikmark OG, Simonsen GS, Sundsfjord A, Nielsen KM.

J Antimicrob Chemother. 2010 Sep;65(9):1894-906. doi: 10.1093/jac/dkq219. Epub 2010 Jun 17.

43.

Urinary tract isolates of Enterobacteriaceae from hospitalized patients in the Arkhangelsk region, Russia: antimicrobial susceptibility and characterization of extended-spectrum beta-lactamases strains.

Vorobieva V, Naseer U, Bazhukova T, Semenova N, Haldorsen BC, Aasnaes B, Simonsen GS, Sundsfjord A.

Scand J Infect Dis. 2010 Oct;42(10):797-800. doi: 10.3109/00365541003798292. No abstract available.

PMID:
20438286
44.

[The pandemic--an afterthought].

Ulvestad E, Swensen E, Simonsen GS, Schei E.

Tidsskr Nor Laegeforen. 2010 Jan 28;130(2):169-71. doi: 10.4045/tidsskr.10.0023. Norwegian.

45.

PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501- and pHTbeta-related replicons associated with glycopeptide resistance and stabilizing toxin-antitoxin systems.

Rosvoll TC, Pedersen T, Sletvold H, Johnsen PJ, Sollid JE, Simonsen GS, Jensen LB, Nielsen KM, Sundsfjord A.

FEMS Immunol Med Microbiol. 2010 Mar;58(2):254-68. doi: 10.1111/j.1574-695X.2009.00633.x. Epub 2009 Nov 17.

46.

Real-time polymerase chain reaction for detection of low-intensity Schistosoma japonicum infections in China.

Lier T, Simonsen GS, Wang T, Lu D, Haukland HH, Vennervald BJ, Hegstad J, Johansen MV.

Am J Trop Med Hyg. 2009 Sep;81(3):428-32.

PMID:
19706908
47.

Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.

Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A; Norwegian ESBL Study Group.

APMIS. 2009 Jul;117(7):526-36. doi: 10.1111/j.1600-0463.2009.02465.x.

PMID:
19594493
48.

[Oral antibiotic treatment of urinary tract infections in children].

Klingenberg C, Småbrekke L, Døllner H, Simonsen GS.

Tidsskr Nor Laegeforen. 2009 Jun 25;129(13):1342-4. doi: 10.4045/tidsskr.09.0092. Review. Norwegian.

49.

Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.

Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A.

Clin Microbiol Infect. 2010 Feb;16(2):171-8. doi: 10.1111/j.1469-0691.2009.02861.x. Epub 2009 Jun 22.

50.

Factors affecting the reversal of antimicrobial-drug resistance.

Johnsen PJ, Townsend JP, Bøhn T, Simonsen GS, Sundsfjord A, Nielsen KM.

Lancet Infect Dis. 2009 Jun;9(6):357-64. doi: 10.1016/S1473-3099(09)70105-7. Review.

PMID:
19467475

Supplemental Content

Loading ...
Support Center